Intelligence Platform
Patents
Browse 55 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10961535
Compositions and agents against hepatitis B virus and uses thereof
granted patentUS 10815463
Messenger UNA molecules and uses thereof
granted patentUS 10781169
Method of synthesis of an ionizable cationic lipid
granted patentUS 10731154
Acyl-amino-LNA and/or hydrocarbyl-amino-LNA oligonucleotides
granted patentUS 10683500
UNA oligomers having reduced off-target effects in gene silencing
granted patentUS 10604758
Therapeutic oligomers for treating amyloidosis
granted patentUS 10556861
Ionizable cationic lipid for RNA delivery
granted patentUS 10519447
Therapeutic UNA oligomers and uses thereof
granted patentUS 10487105
Trinucleotide MRNA cap analogs
granted patentUS 10457945
UNA oligomers for therapeutics with prolonged stability
granted patentUS 10421964
UNA oligomers and compositions for treating amyloidosis
granted patentUS 10399937
Ionizable cationic lipid for RNA delivery
granted patentUS 10383952
Ionizable cationic lipid for RNA delivery
granted patentUS 10369232
Allele selective gene editing and uses thereof
granted patentUS 10227302
Ionizable cationic lipid for RNA delivery
granted patentUS 9982259
Transthyretin allele selective UNA oligomers for gene silencing
granted patentUS 9962449
MultiLigand agent for drug delivery
granted patentUS 9951002
Ionizable cationic lipid for RNA delivery
granted patentUS 9944929
UNA single stranded oligomers for therapeutics
granted patentUS 9896413
Ionizable cationic lipid for RNA delivery
granted patentUS 9856475
Formulations for treating amyloidosis
granted patentUS 9850202
Ionizable cationic lipid for RNA delivery
granted patentUS 9670152
Ionizable cationic lipid for RNA delivery
granted patentUS 9593077
Ionizable cationic lipid for RNA delivery
granted